[Prospective study of the results at 2 years of one or two cycles of BCG endovesical instillations in the urothelial tumors of the bladder pT1 G3 after completed transurethral resection].
Rischmann
Pascal
P
Service d'Urologie, Transplantation rénale et Andrologie, CHU Rangueil, Toulouse, France.
Gamé
Xavier
X
Mazerolles
Catherine
C
Bittard
Hugues
H
Bouchot
Olivier
O
Descottes
Jean-Luc
JL
Chopin
Dominique
D
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000283:Administration, Intravesical; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001500:BCG Vaccine / Q000008:administration & dosage*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine